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Abstract
Introduction 
Few studies have evaluated possible racial/ethnic disparities in chronic disease prevalence among US Air Force active-
duty members. Because members have equal access to free health care and preventive screening, the presence of health 
disparities in this population could offer new insight into the source of these disparities. Our objective was to identify 
whether the prevalence of 4 common chronic diseases differed by race/ethnicity in this population.
Methods 
We compiled de-identified clinical and administrative data for Air Force members aged 21 or older who had been on 
active duty for at least 12 months as of October 2008 (N = 284,850). Multivariate logistic regression models were used 
to determine the prevalence of hypertension, dyslipidemia, type 2 diabetes, and asthma by race/ethnicity, controlling 
for rank and sex.
Results 
Hypertension was the most prevalent chronic condition (5.3%), followed by dyslipidemia (4.6%), asthma (0.9%), and 
diabetes (0.3%). Significant differences were noted by race/ethnicity for all conditions. Compared with non-Hispanic 
whites, the prevalence of all chronic diseases was higher for non-Hispanic blacks; disparities for adults of other 
minority race/ethnicity categories were evident but less consistent.
Conclusion 
The existence of racial/ethnic disparities among active-duty Air Force members, despite equal access to free health 
care, indicates that premilitary health risks continue after enlistment. Racial and ethnic disparities in the prevalence of 
these chronic diseases suggest the need to ensure preventive health care practices and community outreach efforts are 
effective for racial/ethnic minorities, particularly non-Hispanic blacks.
Introduction
Non-Hispanic black active-duty members of the military are 87% more likely to be hospitalized for asthma (1) and 
twice as likely to develop type 2 diabetes (2) as their non-Hispanic white counterparts. Similarly, compared with non-
Hispanic whites, Hispanics are 29% more likely to be hospitalized for asthma (1) and 60% more likely to develop 
diabetes (2). Outside of the military, racial/ethnic disparities have been consistently identified in the US health care 
system (3), particularly in the prevalence of hypertension (4,5), dyslipidemia (4,6), diabetes (7,8), and asthma (9,10).
Throughout the US Air Force (USAF) health care system, standards for health care access are the same, regardless of 
geographic area, which helps to ensure each active-duty member receives the same level of health care. Additionally, 
every USAF active-duty member has at least a high school diploma and has been screened for pre-existing health 
conditions; once on active duty, each member is provided an equal housing benefit (based on rank) and has the same 
community resources, regardless of race/ethnicity. Collectively, the active-duty population in the USAF provides a 
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unique opportunity to examine the presence of health disparities in a homogenous population of different racial/ethnic 
backgrounds.
Despite some evidence of disparities in asthma control and diabetes incidence, each military member receives the 
same comprehensive health care benefits with a regular household income, adequate housing, and an additional food 
allowance as part of his or her military benefits. Because of these factors, we hypothesized that no clinically significant 
disparities would be noted.
Although consistent racial/ethnic disparities in chronic diseases have been identified outside of the military, and 2 
studies have found disparities for military members in asthma hospitalization and the incidence of type 2 diabetes, the 
prevalence of asthma and diabetes, by race/ethnicity, has not been established. Similarly, disparities in prevalence of 
cardiovascular diseases, including hypertension and dyslipidemia, have not been determined in the military 
population. The purpose of this study was to determine whether disparities exist in the prevalence of hypertension, 
dylipidemia, diabetes, and asthma among active-duty USAF members.
Methods
We conducted a secondary analysis of existing clinical and administrative data for this descriptive, correlational study. 
The institutional review board (IRB) at Johns Hopkins University, the USAF Surgeon General’s Research Oversight 
and Compliance Division, the IRB at the Uniformed Services University of the Health Sciences, and the USAF Clinical 
Informatics Branch approved the study. The USAF Clinical Informatics Branch compiled data in October 2008 for the 
preceding 24 months.
Chronic disease screening
Active-duty members are carefully screened before enlistment to ensure they are healthy enough for a military 
deployment (11). Annually, each active-duty member completes a preventive health assessment, which evaluates any 
new diagnoses received during the previous year and screens for chronic diseases, as recommended by the US 
Preventive Services Task Force. Any new medical diagnoses are also noted at that time and reviewed by the provider to 
determine the need for a Medical Evaluation Board, a process designed to determine whether soldiers’ long-term 
medical conditions enable them to continue to meet medical retention standards. The Medical Evaluation Board also 
provides the opportunity for military physicians to clearly document soldiers’ medical conditions and any duty 
limitations these may cause. All clinical information is maintained in a Department of Defense electronic medical 
record system and tracked in the Air Force medical readiness database (11).
Study variables
We compiled de-identified clinical and administrative data from all USAF members aged 21 or older and on active duty 
at least 12 months as of October 2008 (N = 284,850). Higher ranks (1-, 2-, 3-, and 4-star generals) were not included 
in the original sample because of their small numbers (n = 204) and the personalized health care support they receive. 
Members on active duty less than 12 months were also excluded because newly enlisted or commissioned members 
have up to 12 months to get an annual preventive health assessment (11). Members with a rank of “other” (n = 1,120) 
and/or a race/ethnicity category of “other/declined” (n = 6,762) were subsequently excluded from further analysis, for 
a final sample size of 277,001.
Sex, race/ethnicity, and rank category were identified through the Defense Enrollment Eligibility Reporting System. 
Five categories were used to identify race/ethnicity: American Indian/Alaska Native, Asian/Pacific Islander, non-
Hispanic black, non-Hispanic white, and Hispanic. Rank was also categorized to ensure that people in the data set 
could not be identified by their demographic information. The 4 rank categories were junior enlisted (from airman 
basic [E-1] through senior airman [E-4]), senior enlisted (from staff sergeant [E-5] through chief master sergeant [E-
9]), junior officer (from second lieutenant [O-1] through captain [O-3]), and senior officer (from major [O-4] through 
colonel [O-6]). A category of Other included remaining enlisted personnel (eg, special agents).
Hypertension was identified for members with 2 or more medical appointments with a credentialed provider in the 
previous 24 months resulting in a primary diagnosis assigned an International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM) code beginning with 401 (12). The clinical definition for the diagnosis was 
based on the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure as a blood pressure reading above 140/90 mm Hg (13). Likewise, dyslipidemia was identified for 
members with 2 or more medical appointments during the previous 24 months with a primary diagnosis of 
dyslipidemia (ICD-9-CM code 272.4) (12), using the clinical definition from the National Heart, Lung, and Blood 
Institute Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults guidelines (14). Members were 
identified as having diabetes or asthma using the National Committee for Quality Assurance’s Health Plan Employer 
Data and Information Set criteria (15). According to these criteria, diabetes is defined by 2 outpatient encounters with 
a diagnosis of diabetes (ICD-9-CM code beginning with 250), 1 emergency department or inpatient admission with 
diabetes, or receiving insulin or oral hypoglycemic/antihyperglycemic medications — excluding patients with a 
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diagnosis of gestational diabetes, polycystic ovaries, steroid-induced diabetes, or prediabetes (15). Similarly, asthma 
was identified for members who had a least 4 medication-dispensing events, 4 outpatient visits for asthma (ICD-9-CM 
code beginning with 493) with at least 2 medication-dispensing events, or 1 emergency department or inpatient 
admission with a principal diagnosis of asthma (15).
Appointment data, including medical diagnosis, are entered into the Standard Ambulatory Data Record according to 
individual facility processes and are audited monthly to ensure accuracy. This audit is centrally directed, and health 
care leaders at all levels in the USAF Medical Service oversee the coding accuracy results. Together with the careful 
monitoring of health care quality metrics, these efforts have maintained a high quality of clinical and administrative 
data (16).
Statistical analysis
We summarized demographic characteristics and prevalence of the 4 chronic diseases using descriptive statistics. We 
then created multivariate logistic regression models to calculate the prevalence of each chronic disease, adjusting for 
rank and sex.
Age had a strong nonlinear relationship with the prevalence of chronic diseases; therefore, we created spline terms at 
each 5-year interval, through age 40. This age effect differed by race/ethnicity, sex, and rank, so interaction terms for 
age and each of these independent variables were tested for significance. After a final model was determined for each 
outcome, the predicted prevalence for each race/ethnicity, by age range, was calculated with 95% confidence intervals.
Results
More than half of the study population was aged 30 or younger, and the overall prevalence of the chronic diseases 
studied was low; hypertension was the most prevalent (5.3%), followed by dyslipidemia (4.6%), asthma (0.9%), and 
diabetes (0.3%) (Table 1). After adjustment for sex and rank, the prevalence of all 4 conditions differed significantly by 
race/ethnicity and was positively associated with age; racial/ethnic differences in prevalence also increased with 
increasing age (Table 2).
Compared with non-Hispanic whites, Asian/Pacific Islander and Hispanic members aged 30 or younger had a lower 
prevalence of hypertension. Both American Indian/Alaska Native and non-Hispanic black members had a higher 
prevalence of hypertension in every age category compared with non-Hispanic whites. After the age of 25, 
hypertension prevalence for non-Hispanic blacks was more than double that of non-Hispanic whites in every age 
range.
Non-Hispanic whites had a significantly lower prevalence of dyslipidemia in every age range compared with every 
minority racial/ethnic group.
Similar to the differences noted with hypertension, both Hispanics and non-Hispanic blacks had a significantly higher 
prevalence of diabetes in all age groups compared with non-Hispanic whites. After age 30, the prevalence of diabetes 
for non-Hispanic blacks was more than twice that of non-Hispanic whites in every age range.
The overall prevalence of asthma was significantly lower for non-Hispanic whites in every age range than for all 
racial/ethnic groups.
Discussion
Compared with non-Hispanic white active-duty members in the USAF, non-Hispanic blacks are consistently and 
significantly more likely to be diagnosed with hypertension, dyslipidemia, diabetes, or asthma. Disparities were also 
noted for other racial/ethnic minorities, although these were less consistent.
The overall prevalence of hypertension in this population (5.3%) is consistent with a published prevalence of 6.7% for 
hypertension among 20- to 39-year-olds from the National Health and Nutrition Examination Survey (NHANES) IV 
(5). The NHANES IV workforce study, which was limited to employed participants in NHANES IV, found that Mexican 
Americans demonstrated the lowest prevalence of hypertension at 6.2%, and non-Hispanic blacks had the highest 
prevalence at 12.4% (6). These results are consistent with our findings that Hispanics had the lowest overall prevalence 
of hypertension and non-Hispanic blacks the highest. However, the fact that the prevalence of hypertension for non-
Hispanic blacks was more than double that of non-Hispanic whites was a more pronounced difference and was similar 
to the prevalence observed among older adults (aged 65-84) in NHANES III (17).
The overall prevalence of dyslipidemia in this sample was 4.6%, which was much lower than the overall prevalence of 
16.4% among employed NHANES IV participants aged 20 to 39 (6). This difference could be due to different 
operationalized definitions of dyslipidemia; the NHANES IV workforce study determined dyslipidemia on the basis of 
elevated low-density lipoprotein cholesterol results or a self-report of taking medication to lower cholesterol, rather 
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than coded data from medical appointments. Another potential reason for the difference could be related to the 
entrance standards for the USAF, which exclude many risk factors that can influence the development of dyslipidemia.
The prevalence of dyslipidemia for non-Hispanic whites in our study was 4.46%, the lowest of all racial/ethnic groups. 
This differed from the results of the NHANES IV workforce study, which found the highest rates for non-Hispanic 
whites, at 18.0% (6). However, in a systematic review of cardiovascular risk factors, no minority racial/ethnic group 
has consistently demonstrated a higher prevalence of high cholesterol than whites (7). The NHANES IV workforce 
study found a 2.4% prevalence of diabetes (6). The prevalence of diabetes for active-duty USAF members was much 
lower, at 0.3%. This difference could be due to differing definitions of diabetes; the NHANES IV workforce study 
determined diabetes based on fasting blood glucose levels (6). However, a previous study found that the incidence of 
diabetes in the military is consistent with the incidence in a nonmilitary population (2), so the lower prevalence is 
likely due to pre-enlistment screening that excludes potential applicants who have already developed diabetes or have 
risk factors that can lead to diabetes, including an elevated body mass index. Additionally, uncontrolled diabetes is 
grounds for medical discharge from the USAF; some members with diabetes may have been unaccounted for by our 
study for this reason.
Although we found that the overall prevalence of diabetes was lower for all race/ethnicity groups than what was 
reported for the US population (6), the disparity for non-Hispanic blacks and Hispanics in our population is similar to 
what has been reported in prior studies of military (2) and nonmilitary (7) populations. However, in this sample, 
American Indian/Alaska Native members demonstrated a lower prevalence of diabetes compared with non-Hispanic 
whites. This finding is not consistent with previously published studies outside of the military (7). Pre-enlistment 
screening may exclude American Indian/Alaska Native members who are at higher risk for developing diabetes or 
these members may be more likely to develop uncontrolled diabetes and to be medically discharged; however, possible 
causes were beyond the scope of this study.
Prevalence of asthma in our study population was 0.9%, much lower than the overall prevalence from the Behavior 
Risk Factor Surveillance System of 7.7% for adults (10). This difference in overall prevalence is likely because asthma 
diagnosed before age 12 is a disqualification for entry into the military (11).
Despite the higher prevalence of the chronic diseases for racial or ethnic minorities compared with non-Hispanic 
whites, there is no evidence that that these members are less likely to participate in preventive care activities. In fact, a 
previous analysis from this population indicated that among active-duty members younger than 30 (more than half the 
sample), non-Hispanic blacks were significantly more likely to have a current preventive health assessment compared 
with non-Hispanic whites (P < .05) (18).
Outside of the military, racial/ethnic health disparities are attributed to interconnected factors, including racism (19), 
social and economic factors (20), and access to health care (21). Health literacy, another factor in health disparities, is 
also associated with poor outcomes but not necessarily with the overall use of health care (22).
The reasons for persistent racial and ethnic disparities in the prevalence of chronic diseases among a prescreened 
USAF population with equitable health care and living conditions are complex. However, because disparities have been 
identified outside of the military setting (3), pre-enlistment screening and subsequent health care and community 
resources likely cannot completely overcome at least 18 years of prior health neglect or culturally ingrained health 
habits and beliefs. In fact, several recent studies have linked childhood factors to long-term health outcomes; low 
socioeconomic status and experiencing a high number of adversities during childhood are associated with poor 
physical capabilities (23) and a high risk of developing diabetes (24).
Targeted interventions are effective at addressing disparities in the prevalence of chronic diseases (25). Just as 
important, however, is the need to acknowledge the effect of disparities on the overall health of men and women who 
enlist in the USAF and other military services. A concerted effort to understand and design culturally sensitive 
prevention efforts is the first step to address these disparities. Tracking existing population health metrics by 
race/ethnicity may also help to identify problems (and successes) and ensure that health disparities are adequately 
addressed.
Relying on existing clinical and administrative data has several inherent disadvantages, primarily the inability to 
completely account for the unique circumstances and risk factors of each person. A factor that should be considered is 
the overall rate of medical discharges from the military for these chronic diseases; however, these data were not 
available for analysis or comparison. Also, differences in personal health care–seeking behaviors may directly 
influence the findings because the diagnosis of these chronic diseases in this study relies on existing data from 
individual encounters. Some members may have met diagnostic criteria for 1 of the 4 chronic diseases included in this 
study but avoided screening activities.
We were, however, able to use data collected on every active-duty member in the USAF who met eligibility criteria, and 
to compare among all race/ethnicity, sex, and rank categories. Therefore, we were not bound by selection bias or a 
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limited sample size. Our findings provide a reference point for future research examining health outcomes of active-
duty military members by race/ethnicity.
The racial and ethnic disparities in the prevalence of the 4 chronic diseases we studied suggest the need to ensure 
effective preventive health care practices and community outreach efforts for racial/ethnic minorities, particularly non
-Hispanic blacks.
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Tables 
 
Table 1. Demographic Characteristics and Prevalence of Chronic Diseases 
Among All Active-Duty US Air Force Members (N = 284,850),  2008
Characteristic n (%)
Race/ethnicity
American Indian/Alaska Native 2,544 (0.9)
Asian/Pacific Islander 13,295 (4.7)
Black, non-Hispanic 41,970 (14.7)
White, non-Hispanic 203,857 (71.6)
Hispanic 16,422 (5.8)
Other/declined to respond 6,762 (2.4)
Sex
Male 230,579 (80.9)
Female 54,271 (19.0)
Age, y
21-25 85,881 (30.1)
26-30 70,318 (24.7)
31-35 47,999 (16.9)
36-40 43,519 (15.3)
≥41 37,133 (13.0)
Rank category
a
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Characteristic n (%)
Junior enlisted (E1-E4) 89,377 (31.4)
Senior enlisted (E5-E9) 132,821 (46.6)
Junior officer (O1-O3) 35,500 (12.5)
Senior officer (O4-O6) 26,032 (9.1)
Other (eg, special agent) 1,120 (0.4)
Chronic diseases
Hypertension 15,128 (5.3)
Dyslipidemia 12,987 (4.6)
Diabetes 892 (0.3)
Asthma 2,477 (0.9)
 Aged ≥21 and on active duty ≥12 months (excluding officers with the rank of general). 
 Defined by the presence of appropriate International Classification of Diseases, Ninth Revision, Clinical Modification codes 
in the medical record for the preceding 2 years (12).
 
Table 2. Prevalence of Chronic Diseases, by Race/Ethnicity, Among Active-
Duty US Air Force Members, 2008
Chronic 
Disease /Age
Non-Hispanic 
White, % 
(95% CI) (n = 
203,015)
American 
Indian/Alaska 
Native, % (95% CI) 
(n = 2,533)
Asian/Pacific 
Islander, % (95% 
CI) (n = 13,253)
Non-Hispanic 
Black, % 
(95% CI) (n = 
41,861)
Hispanic, % 
(95% CI) (n 
= 16,339)
Hypertension
21-25 y 0.98 (0.98-0.99) 1.22 (1.19-1.25) 0.86 (0.86-0.87) 1.87 (1.86-
1.89)
0.81 (0.80-
0.83)
26-30 y 2.24 (2.23-2.25) 2.67 (2.59-2.75) 2.03 (2.00-2.07) 4.84 (4.81-
4.88)
1.98 (1.96-
1.99)
31-35 y 4.22 (4.21-4.24) 5.42 (5.23-5.62) 5.51 (5.41- 5.61) 9.53 (9.46-
9.61)
4.17 (4.12-
4.22)
36-40 y 8.15 (8.12-8.19) 10.02 (9.61-10.42) 10.96 (10.74-11.18) 17.61 (17.48-
17.75)
8.14 (8.03-
8.26)
≥41 y 12.92 (12.87-
12.98)
14.75 (14.23-15.27) 18.3 (17.93-18.66) 27.6 (27.41-
27.79)
14.31 (14.06-
14.57)
Overall 4.57 (4.55-4.59) 4.5 (4.32-4.68) 4.62 (4.52-4.72) 9.57 (9.48-
9.66)
4.33 (4.26-
4.41)
Dyslipidemia
21-25 y 0.55 (0.55-0.55) 0.76 (0.74-0.79) 0.80 (0.79-0.81) 0.65 (0.64-
0.65)
0.76 (0.75-
0.77)
26-30 y 1.64 (1.64-1.65) 2.2 (2.13-2.27) 2.24 (2.21-2.27) 1.82 (1.80-
1.83)
1.98 (1.95-
2.00)
31-35 y 4.14 (4.12-4.16) 5.52 (5.27-5.77) 5.42 (5.31-5.52) 4.54 (4.49-
4.59)
4.73 (4.66-
4.80)
36-40 y 8.46 (8.42-8.49) 11.54 (11.03-12.04) 11.23 (10.99-11.48) 9.52 (9.42-
9.62)
9.79 (9.64-
9.95)
≥41 y 13.89 (13.83-
13.95)
18.46 (17.66-19.25) 18.8 (18.42-19.17) 15.49 (15.33-
15.64)
16.25 (15.99-
16.50)
b
a
b
a
b
Page 7 of 8CDC - Preventing Chronic Disease: Volume 9, 2012: 11_0136
For Questions About This Article Contact pcdeditor@cdc.gov
Page last reviewed: June 14, 2012
Page last updated: June 14, 2012
Content source: National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA 
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov
Chronic 
Disease /Age
Non-Hispanic 
White, % 
(95% CI) (n = 
203,015)
American 
Indian/Alaska 
Native, % (95% CI) 
(n = 2,533)
Asian/Pacific 
Islander, % (95% 
CI) (n = 13,253)
Non-Hispanic 
Black, % 
(95% CI) (n = 
41,861)
Hispanic, % 
(95% CI) (n 
= 16,339)
Overall 4.46 (4.44-4.49) 4.74 (4.50-4.98) 4.72 (4.61-4.82) 4.83 (4.77-
4.89)
4.87 (4.79-
4.96)
Diabetes
21-25 y 0.04 (0.04-0.04) 0 0.01 (0.01-0.01) 0.06 (0.06-
0.06)
0.10 (0.10-
0.10)
26-30 y 0.08 (0.08-0.08) 0 0.03 (0.03-0.04) 0.13 (0.12-
0.13)
0.12 (0.11-
0.12)
31-35 y 0.16 (0.16-0.16) 0.02 (0.02-0.03) 0.18 (0.18-0.19) 0.46 (0.46-
0.47)
0.30 (0.29-
0.31)
36-40 y 0.40 (0.40-0.40) 0.64 (0.58-0.69) 1.22 (1.17-1.26) 1.31 (1.29-
1.32)
0.92 (0.90-
0.94)
≥41 y 0.82 (0.81-0.83) 1.31 (1.24-1.39) 2.87 (2.78-2.96) 2.30 (2.28-
2.33)
1.68 (1.64-
1.71)
Overall 0.23 (0.23-0.23) 0.20 (0.18-0.22) 0.43 (0.41-0.45) 0.62 (0.61-
0.63)
0.43 (0.42-
0.44)
Asthma
21-25 y 0.41 (0.41-0.41) 0.42 (0.40-0.43) 0.44 (0.44-0.45) 0.63 (0.63-
0.64)
0.55 (0.55-
0.56)
26-30 y 0.61 (0.60-0.61) 0.65 (0.62-0.67) 0.66 (0.65-0.67) 1.02 (1.01-
1.03)
0.81 (0.80-
0.82)
31-35 y 0.96 (0.95-0.96) 1.05 (1.00-1.11) 1.02 (1.00-1.05) 1.55 (1.53-
1.57)
1.22 (1.20-
1.23)
36-40 y 1.22 (1.21-1.23) 1.27 (1.20-1.33) 1.31 (1.28-1.34) 1.96 (1.94-
1.99)
1.53 (1.50-
1.56)
≥41 y 1.23 (1.22-1.24) 1.26 (1.19-1.34) 1.28 (1.25-1.32) 1.87 (1.85-
1.89)
1.46 (1.43-
1.49)
Overall 0.79 (0.78-0.79) 0.75 (0.73-0.77) 0.77 (0.76-0.78) 1.24 (1.23-
1.25)
1.00 (0.99-
1.01)
Abbreviation: CI, confidence interval. 
 Adjusted for sex and rank. 
 Defined by the presence of appropriate International Classification of Diseases, Ninth Revision, Clinical Modification codes 
in the medical record for the preceding 24 months (12).
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